Skip to main content
Tech.euFundingExplorerBeta

Vantis

Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.

Vantis has raised €14M across 2 funding rounds from 8 investors, most recently a Series A round in Mar 2025. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€14M
€13,800,000
Funding rounds
2
Investors
8
distinct backers
Active since
2021-05
latest 2025-03

Funding by year

EUR raised per year
Vantis — funding by year — interactive chart.
Data table
Vantis — funding by year
2021€3.8M
2025€10M

Signals

High confidence
Raise-next likelihood70
base rate 44% for Series A
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
  • ▲ 5y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2025-03-12Series A€10MAngelini Ventures,b2venture,Bayern Kapital,Existing investors,Firstminute Capital,Twip Impact VenturesView deal →
2021-05-03Other€3.8MAngel Investors,btov PartnersView deal →

Similar companies

same sector or country

Global coverage: FundingData